Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/23 16:25 | 8/9/23 | CYCN | Health | Drug | Pharmaceutical Preparations | McGuire Terrance | MA | D | S | 0 | 3.40 | 0 | 0 | 0 | 37 | I | |||||||||||||||
3/1/21 16:23 | 2/25/21 | CYCN | Health | Drug | Pharmaceutical Preparations | Gjino Anjeza | MA | O | CFO | S | -7 | 4.00 | 0 | -2 | -5 | 32 | D | ||||||||||||||
3/1/21 16:17 | 2/25/21 | CYCN | Health | Drug | Pharmaceutical Preparations | Wright Christopher I | MA | O | Chief Me | S | -11 | 3.99 | 0 | -3 | -6 | 43 | D | ||||||||||||||
12/30/20 13:14 | 12/28/20 | CYCN | Health | Drug | Pharmaceutical Preparations | Currie Mark G | MA | O | P,CSO | S | -61 | 3.01 | 0 | -20 | -7 | 252 | D | ||||||||||||||
11/10/20 19:07 | 11/6/20 | CYCN | Health | Drug | Pharmaceutical Preparations | Huyett William | MA | O | CFO | S | -10 | 2.52 | 0 | -4 | -5 | 68 | D | ||||||||||||||
2/25/20 16:11 | 2/21/20 | CYCN | Health | Drug | Pharmaceutical Preparations | Huyett William | MA | O | CFO | S | -18 | 5.12 | 0 | -4 | -5 | 71 | D | ||||||||||||||
12/31/19 17:55 | 12/27/19 | CYCN | Health | Drug | Pharmaceutical Preparations | Currie Mark G | MA | O | P | S.m | -126 | 2.52 | 0 | -50 | -16 | 272 | D | ||||||||||||||
11/12/19 16:26 | 11/8/19 | CYCN | Health | Drug | Pharmaceutical Preparations | Huyett William | MA | O | CFO | S | -8 | 2.05 | 0 | -4 | -5 | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |